About Alexander de Leeuw

Alexander de Leeuw is a senior associate and specialises in national and international patent litigation, with a special focus on pharmaceutical inventions, medical devices and consumer goods. He also regularly deals with the protection of know-how/trade secrets and evidentiary seizures. Alexander has gained significant experience litigating in complex patent cases before the courts in The Hague and the EPO, eg, concerning pemetrexed and CRISPR-Cas9. In addition to his litigation practice, Alexander enjoys writing and teaching about patent law and regularly publishes about the developments regarding trade secrets, software patents and artificial intelligence.